Sigma Planning Corp
JAZZ icon

Sigma Planning Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sigma Planning Corp’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.42M Buy
6,128
+4,119
+205% +$1.02M 0.04% 459
2026
Q2 		$484K Buy
+2,009
New +$440K 0.01% 925
2022
Q1 		– Sell
-1,637
Closed -$209K – 1439
2021
Q4 		$209K Buy
+1,637
New +$215K 0.01% 1263
2021
Q3 		– Sell
-1,478
Closed -$263K – 1440
2021
Q2 		$263K Buy
+1,478
New +$256K 0.01% 1154

Other funds holding JAZZ

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Sigma Planning Corp's JAZZ Position: Q3 2026 in Review

Sigma Planning Corp increased its Jazz Pharmaceuticals (JAZZ) stake by 205% in Q3 2026, buying an estimated $1.02M and bringing the position to 6,128 shares worth $1.42M. The position accounts for 0.04% of the portfolio, ranked #459.

Sigma Planning Corp first reported a position in JAZZ in Q2 2021 and has held it in 4 quarters since. 340 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Sigma Planning Corp held 6,128 shares of Jazz Pharmaceuticals worth $1.42M as of Q3 2026.
  • Sigma Planning Corp bought 4,119 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.02M.
  • Jazz Pharmaceuticals made up 0.04% of Sigma Planning Corp's portfolio in Q3 2026, its #459 holding.
  • Sigma Planning Corp first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
  • 340 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Sigma Planning Corp's 13F filing for Q3 2026, filed 23 Oct 2026.